Published Date: 16-Jun-2020
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Global Clinical Nutrition Market, published by KBV research, The Global Clinical Nutrition Market size is expected to reach $44.7 billion by 2026, rising at a market growth of 6.9% CAGR during the forecast period.
Cancer is expected to be the fast-growing category in the forecast period. This is related to the nutritional deficiency that exists in patients owing to multiple cancer treatments such as chemotherapy, hormone therapy, radiation therapy, surgery, immunotherapy, and stem cell transplant.
Depending on the end-user, the market is categorized into a pediatric, adult, and geriatric. The pediatric segment held the largest share in 2019 and is expected to continue the trend during the forecast period. The growing concern for malnutrition in pediatric patients across the globe is expected to be the key driver for the growth of the pediatric clinical nutrition industry.
North America was the largest revenue contributor to the global clinical nutrition industry in 2019 and is projected to dominate the market over the forecast period owing to a rise in the number of cardiovascular diseases such as coronary heart disease, ischemic stroke, asthma, and few symptoms of cancer, and growth in the geriatric population.
In addition, the U.S. government's plan to encourage comprehensive nutritional care for cancer patients is projected to help drive the market. Furthermore, Asia-Pacific is projected to witness the highest growth over the forecast period due to rising metabolic conditions, high disposable incomes, and enhanced consumer understanding of clinical nutrition products.
Structural Insights: https://www.kbvresearch.com/clinical-nutrition-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Nestle S.A., Lonza Group AG, BASF SE, Ajinomoto Co., Inc., Perrigo Company PLC, and Hero Nutritionals, Inc.
By Route of Administration
Unique Offerings from KBV Research